2015
DOI: 10.1016/j.cyto.2015.07.024
|View full text |Cite
|
Sign up to set email alerts
|

Antibodies enhance CXCL10 production during RSV infection of infant and adult immune cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 42 publications
0
9
0
Order By: Relevance
“…Although AMs suppress the migration (65) and antigen-presentation capacity (66) of DCs and increase the trafficking of antigen to draining lymph nodes (65), our results show that AM depletion in CD169-DTR mice does not affect DCs or their subset frequency and has no effect on the adaptive CD4 + and CD8 + T cell immune responses to RSV infection. CXCL9 and CXCL10 play important roles in RSV-infected mice by recruiting virus-specific T cells to the lungs and promoting viral clearance (39, 67). Multiple cell populations, including epithelial cells and fibroblasts, may induce the production of CXCL9 and CXCL10 in the airways (68).…”
Section: Discussionmentioning
confidence: 99%
“…Although AMs suppress the migration (65) and antigen-presentation capacity (66) of DCs and increase the trafficking of antigen to draining lymph nodes (65), our results show that AM depletion in CD169-DTR mice does not affect DCs or their subset frequency and has no effect on the adaptive CD4 + and CD8 + T cell immune responses to RSV infection. CXCL9 and CXCL10 play important roles in RSV-infected mice by recruiting virus-specific T cells to the lungs and promoting viral clearance (39, 67). Multiple cell populations, including epithelial cells and fibroblasts, may induce the production of CXCL9 and CXCL10 in the airways (68).…”
Section: Discussionmentioning
confidence: 99%
“…Ìn addition, we previously published a microarray database regarding PBMCs from healthy adults that are untreated or stimulated with RSV. The methods have been described by our group previously 35 and this microarray data has been deposited in the NCBI Gene Expression Omnibus (GEO) database under GEO Series accession number (GSE59391) 35. We combined these two microarray databases for the current study.…”
Section: Methodsmentioning
confidence: 99%
“…A similar cut‐off value of 4‐fold difference was used for the microarray data published by Vissers et al. 35 to identify genes that are upregulated In vitro upon exposure of adult PBMCs to RSV. We then determined which genes were upregulated in both microarray analyses, being upregulated genes derived from whole blood from RSV‐infected infants and upregulated genes derived from In vitro RSV‐stimulated adult PBMCs, to identify clinically relevant genes that could be investigated in our model of PBMCs.…”
Section: Methodsmentioning
confidence: 99%
“…Vaccine-enhanced disease was observed in a 1960s clinical trial that used formalin-inactivated RSV (FI-RSV)-immunized infants, in whom poorly neutralizing antibodies could form immune complexes with RSV and result in enhanced diseases (Delgado et al, 2009;Polack et al, 2002). However, palivizumab (brand name Synagis ® ), which is a neutralizing antibody that targets F protein of RSV, was an exception to this observation and has been used to protect children at high risk for severe lung disease from RSV (Vissers et al, 2015;Weltzin and Monath, 1999).…”
Section: Introductionmentioning
confidence: 94%